{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T10:18:23Z","timestamp":1794910703659,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ahjo.2026.100942","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:46Z","timestamp":1791357406000},"page":"100942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Percutaneous left atrial appendage occlusion versus oral anticoagulation in atrial fibrillation: A pragmatic meta-analysis of randomized trials within the DOAC era"],"prefix":"10.1016","volume":"71","author":[{"given":"Gabriel Moraes","family":"Kuniyoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Zoppi","family":"Campane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Clara Vitorino","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Ryoshim","family":"Kuniyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2024","key":"10.1016\/j.ahjo.2026.100942_bb0005","first-page":"e1","article-title":"ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100942_bb0010","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year outcomes after left atrial appendage closure","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0015","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin","volume":"8","author":"Price","year":"2015","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ahjo.2026.100942_bb0020","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ahjo.2026.100942_bb0025","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer amulet left atrial appendage occluder versus Watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.ahjo.2026.100942_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013750","article-title":"Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR left atrial appendage occlusion registry","volume":"17","author":"Kapadia","year":"2024","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ahjo.2026.100942_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacc.2025.03.535","article-title":"3-year clinical outcomes comparing the Amulet vs Watchman FLX for left atrial appendage closure in patients with atrial fibrillation","volume":"86","author":"Galea","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0040","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network meta-analysis of initial antithrombotic regimens after left atrial appendage occlusion","volume":"82","author":"Carvalho","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0045","first-page":"45","article-title":"Left atrial appendage occlusion versus direct oral anticoagulants or warfarin in atrial fibrillation: a network meta-analysis of randomized trials","volume":"192","author":"Abdelfattah","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0050","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-Year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacep.2026.06.033","article-title":"Left atrial appendage closure vs anticoagulation for stroke prevention in atrial fibrillation: meta-analysis of randomized trials","author":"Turagam","year":"2026","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/jcm15145529","article-title":"Left atrial appendage occlusion versus medical therapy in atrial fibrillation: a systematic review and meta-analysis","volume":"15","author":"Khan","year":"2026","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ahjo.2026.100942_bb0070","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euag159","article-title":"Long-term efficacy and safety of left atrial appendage closure vs. oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"28","author":"Karakasis","year":"2026","journal-title":"Europace"},{"key":"10.1016\/j.ahjo.2026.100942_bb0075","article-title":"Left atrial appendage closure vs direct oral anticoagulants in atrial fibrillation","volume":"5","author":"Chan","year":"2026","journal-title":"JACC: Adv."},{"key":"10.1016\/j.ahjo.2026.100942_bb0080","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.ahjo.2026.100942_bb0085","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ahjo.2026.100942_bb0090","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ahjo.2026.100942_bb0095","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100942_bb0100","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa2517213","article-title":"Left atrial appendage closure or anticoagulation for atrial fibrillation","volume":"394","author":"Doshi","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100942_bb0105","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMoa2513310","article-title":"Left atrial appendage closure or medical therapy in atrial fibrillation","volume":"394","author":"Landmesser","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ahjo.2026.100942_bb0110","article-title":"Antithrombotic treatment after stroke due to intracerebral haemorrhage","volume":"1","author":"Cochrane","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ahjo.2026.100942_bb0115","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.amjcard.2019.04.027","article-title":"Thromboembolism in the absence of atrial fibrillation","volume":"124","author":"Smietana","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0120","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.amjcard.2019.07.037","article-title":"The interaction among atrial thromboembolism, atrial fibrillation, and atrial cardiomyopathy","volume":"124","author":"Reiffel","year":"2019","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0125","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/j.jacep.2018.09.007","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion: a meta-analysis","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjcard.2023.07.102","article-title":"Meta-analysis of the outcomes of peri-device leak after left atrial appendage closure","volume":"204","author":"Mostafa","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0135","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/j.jcin.2023.10.046","article-title":"Device-related thrombus after left atrial appendage occlusion","volume":"16","author":"Alkhouli","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ahjo.2026.100942_bb0140","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacep.2022.01.014","article-title":"New left atrial appendage devices: revelation or conformal?","volume":"8","author":"Boersma","year":"2022","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.ahjo.2026.100942_bb0145","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euae188","article-title":"Incidence and predictors of 2-year mortality following percutaneous left atrial appendage occlusion in the EWOLUTION trial","volume":"26","author":"Aarnink","year":"2024","journal-title":"Europace"},{"key":"10.1016\/j.ahjo.2026.100942_bb0150","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/ehjci\/jeaf078","article-title":"Imaging assessment after percutaneous left atrial appendage closure: from immediate to long-term follow-up","volume":"26","author":"Cepas-Guill\u00e9n","year":"2025","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ahjo.2026.100942_bb0155","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamacardio.2024.2335","article-title":"Low-dose direct oral anticoagulation vs dual antiplatelet therapy after left atrial appendage occlusion: the ADALA randomized clinical trial","volume":"9","author":"Freixa","year":"2024","journal-title":"JAMA Cardiol."}],"container-title":["American Heart Journal Plus: Cardiology Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226002314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666602226002314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T09:35:29Z","timestamp":1794908129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666602226002314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"alternative-id":["S2666602226002314"],"URL":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100942","relation":{},"ISSN":["2666-6022"],"issn-type":[{"value":"2666-6022","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous left atrial appendage occlusion versus oral anticoagulation in atrial fibrillation: A pragmatic meta-analysis of randomized trials within the DOAC era","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal Plus: Cardiology Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahjo.2026.100942","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100942"}}